Effect of Midazolam Bolus on Eleveld and Schnider TCI (Target Controlled Infusion) Models

NCT05800288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-10-19

No results posted yet for this study

Summary

No trials have evaluated the effect of a Midazolam bolus (routinely used for premedication before general anesthesia) on the Concnetration at the effector site of Propofol (CeP) of Eleveld and Schnider TCI models, routinely used for general anesthesia delivery.

Conditions

  • Propofol
  • Anesthesia Brain Monitoring

Interventions

DRUG

Propofol

Patients will be observationally included in the Elveld TCI or Schnider TCI group. The TCI model is choosen at anesthesiologist's discreption, as suggested in literature

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05800288 on ClinicalTrials.gov